Indolcarbinol

N/A

Report date: 2026/03/26 20:00:17
NME

Base Information

Drug NameIndolcarbinol
Drug Alias NameintrinolIndole-3-carbinolIndinol Forto
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN inhibitors
TargetsPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN
Therapy Area/IndicationsEndometriosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRussian Federation
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlcea Llc
China Registration ClassN/A

Develop Information

Active CompaniesBeth Israel Deaconess Medical CenterAlcea Llc
Inactive CompaniesN/A
Active IndicationsEndometriosisNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A